Amgen (AMGN) markets Mvasi and Kanjinti, biosimilar versions of Avastin and Herceptin, respectively in the United States, and Kanjinti and Amgevita, biosimilar of Humira, in the EU.
source https://finance.yahoo.com/news/amgen-presents-positive-data-rituxan-143602398.html?.tsrc=rss
blaineonline.finance.blog 